![]() |
|
|
3 Department of Pediatrics, Children's Hospital, Boston Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115; 4 Department of Occupational and Environmental Health, Maggiore Policlinico Hospital, Mangiagalli and Regina Elena IRCCS Foundation, and University of Milan, Milan 20122, Italy; and 5 Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115
* To whom correspondence should be addressed. E-mail: rowright{at}hsph.harvard.edu.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although metals have multiple effects on biological systems, an understudied effect is their role in programming gene expression. A growing body of evidence suggests that metals may influence epigenetic phenomena which regulate the expression of genes and ultimately their protein products. In this article, we focus on the neurotoxic properties of metals and their ability to mimic the pathways of Fe metabolism. In addition, we review the data on the effects of metals on DNA methylation and discuss how these properties might explain fetal origins of adult disease.
Neurotoxicity of Fe
Research on Fe and neurodevelopment has focused primarily on the effects of Fe deficiency anemia. Nevertheless, there is evidence that excess Fe stores in pregnancy and newborns may be toxic. Several studies have noted a "U"-shaped association between maternal hemoglobin or serum ferritin (SF) and low birth weight. This association has been attributed by some investigators to a failure of normal plasma volume expansion in pregnancy (1) or to inflammation from undiagnosed perinatal infection, as serum ferritin is a well-known acute-phase reactant. Goldenberg et al. (2) showed that high trimester-2 maternal Fe stores not only predicted low birth weight and prematurity but also predicted decreases in IQ in children who were followed until age 5 y. More recently, Tamura et al. (3) demonstrated a U-shaped association between infant umbilical cord SF and lower IQ scores at age 5 y in an Alabama birth cohort. Subjects in the highest quartile of SF at birth were 3.3-fold more likely than the middle 2 quartiles (95% confidence interval: 1.2–9.1) to score below the 15th percentile in full-scale IQ. Similar findings were reported for subjects in the lowest quartile for SF, suggesting that both high and low Fe stores are associated with poor developmental outcomes. Animal studies also support these findings. Fe supplementation of rats produced a decrease in motor activity and exploratory and stereotyped behaviors similar to that of late iron deficiency (ID) anemia (4). Another report by Fredriksson et al. showed that mice administered large oral doses of Fe at postnatal d 10–12 had long-term effects on spontaneous motor behavior, with the animals showing a lack of habituation of spontaneous activity and poorer performance in the radial maze test at 3 mo of age (5).
Such findings, if validated, will undoubtedly complicate public health efforts at eradicating Fe deficiency but should not be dismissed as confounding from the effects of ferritin as an acute-phase reactant. Excess Fe is known to be neurotoxic in adults, and the possibility that it may also produce health effects in pregnant women and newborns must also be investigated.
Neurotoxicity of Mn
Unlike As and Pb, Mn is not only a toxic metal but also an essential nutrient and is required for many essential enzymatic reactions (6,7). Although Mn deficiencies are possible, they rarely occur in humans. The primary mechanisms of Mn neurotoxicity are not well understood but appear to involve increased oxidative damage to neuronal cells (8,9). With respect to potential developmental neurotoxicity, Tran et al. demonstrated that increased dietary Mn supplements fed to lactating dams were associated with decreased striatal dopamine levels as well as significant increases in passive avoidance errors (6,10). Excessive Mn intake from environmental and occupational settings is associated with several negative health outcomes including lethargy, tremor, and psychological and neurological disorders resembling both schizophrenia and Parkinson's disease (11). Numerous occupational studies document memory loss, anxiety, nervousness, impulsive-compulsive behaviors, psychotic experiences, fatigue, and sleep disturbances (12–14).
The main sources of environmental exposure to Mn are through the diet, inhalation, and drinking contaminated water. At least 4 studies have reported toxicity from excess Mn in children. In Chinese children, exposure to elevated Mn concentrations in drinking water were associated with lower scores on tests of short-term memory, manual dexterity, and visual-perceptual speed (15). A pilot study of children with attention deficit hyperactivity disorder demonstrated an association with this condition and higher hair levels of Mn (16). Wright et al. demonstrated an inverse association between hair Mn and IQ in grade-6 children in Oklahoma (17). Finally, Wasserman et al. (18) found associations between high water Mn levels and full-scale, performance, and verbal IQ among 142 children 10 y of age in Bangladesh.
Neurotoxicity of As
Arsenic has traditionally been classified as a peripheral neurotoxin with a clinical manifestation of polyneuropathy, but recent evidence from animal studies suggests that As also affects the central nervous system and that prenatal exposures influence neurological phenotypes in offspring. Arsenic has been shown to pass readily through the placenta, and mice born to As-exposed dams had elevated As concentrations in their brain tissue (19). Others have shown that rats born to dams dosed orally with As had learning and behavioral deficits (20). Compared with unexposed controls, rats exposed to As prenatally had increased spontaneous locomotor activity and increased errors on memory test (20). Mechanistically, these deficits may be caused by increased oxidative toxicity. Arsenic in drinking water will produce a dose-dependent decrease in glutathione, superoxide dismutase, and catalase in the brain, indicating neurotoxic oxidative stress (21,22) Among rats exposed to As during pregnancy, fetal brain neurons underwent apoptotic changes and neuronal necrosis (23).
Historical case studies report As neurotoxicity in Japanese infants who survived an outbreak of As poisoning from contaminated milk powder in 1955 (24). Recent epidemiological studies include a cross-sectional study in Mexico that found that higher levels of urinary As were significantly related to poorer performance on verbal memory, verbal comprehension, and long-term memory (25). These findings are consistent with results from studies in Taiwan, the United States, and Bangladesh (26,18).
Neurotoxicity of Cd
The neurotoxicity of Cd in children was investigated in several studies in the 1970s and 1980s but has received little attention since. In most of these studies, the biomarker of exposure was the concentration of Cd in hair. In case-control studies in which the hair concentration of Cd of a clinically defined group was compared with that of a reference group, higher concentrations were reported in children with mental retardation (27–29), and learning difficulties or dyslexia (30,31). In cohort studies, Thatcher et al. (32,33) reported that the concentration of Cd in hair was inversely related to adjusted IQ. Other investigators (34) have reported associations between hair Cd and children's performance on visual-motor tasks. However, No population-based studies of the neurotoxicity of Cd have been conducted in children to date.
Neurotoxicity of Cu and Zn
Like Fe, most of the literature on the neurotoxicity of Cu and Zn centers around nutritional deficiency and its effect on brain (35). Also, as for Fe, there is evidence of neurotoxicity when these metals are found in excess in the brain. Cu is a transition metal, and consequently, its metabolism and toxicity are similar to those of Fe and Mn. As for Fe, genetic diseases of excess Cu retention are well described and have significant neurologic sequelae. Wilson's disease is the most common of these diseases, and the presenting complaint for this genetic disorder frequently includes neurobehavioral changes resembling schizophrenia (36). These neurologic findings may even precede other findings such as liver disease. Descriptions of environmental or excess dietary Cu producing subclinical neurobehavioral effects are very rare, but these have not been systematically studied. Excess brain Cu is a common finding in neurodegenerative diseases such as Alzheimer's disease.
Zn deficiency has long been known to impact neurodevelopment adversely, but the effects of excess Zn on neurodevelopment are essentially unknown. Excess Zn, like excess Fe and Cu, is a common finding in neurodegenerative disease (37). Zn finger proteins are key transcriptional elements that regulate the cellular response to metal toxicity among other processes. Excess Zn is involved in the neuronal injury observed in cerebral ischemia, epilepsy, and brain trauma. Toxic Zn accumulation may result from either transsynaptic Zn movement or mobilization from intracellular sites, such as Zn flux through receptor-associated calcium channels, voltage-sensitive calcium channels, or Zn-sensitive membrane transporters (38). The mechanisms by which Zn exerts its neurotoxicity include mitochondrial production of reactive oxygen species and the disruption of metabolic enzymes, ultimately leading to activation of apoptotic processes. As with Cu, Fe, and Mn, an exciting new area of research is the role of Zn metabolism in Alzheimer's disease as a trigger for amyloid-ß aggregation and neuronal plaque formation.
As we previously noted, excess Fe, particularly during pregnancy, has been associated with neurodevelopmental outcomes later in life, and similar studies of Cu and Zn in pregnancy are sorely needed.
Neurotoxicity of Pb and methylmercury
The literature supporting the neurodevelopmental toxicity of both Pb and methylmercury is extensive, and a comprehensive summary of either metal is beyond the scope of this article. Although controversy still exists regarding the levels at which Pb toxicity manifests itself clinically, there is widespread acceptance that Pb is neurotoxic. With respect to methylmercury, for which the primary exposure source is fish consumption, the most pressing research question at present is how to balance the beneficial effects of fish consumption vs. the toxic effects of methylmercury.
Metal mixtures and neurodevelopment
There are few studies that have reported on the effect of chemical mixtures in humans despite the fact that many metals are commonly encountered as mixtures in the environment. Initial studies merely reported correlations among markers of internal metal dose, including a positive correlation between blood Pb and Mn (39,40), and a positive correlation between urine As and blood Pb among children (25).
With respect to neurologic outcomes, we are unaware of any clinical data investigating joint exposures to Mn and Pb. However, animal studies provide compelling evidence that exposure to both Mn and Pb lead to synergistic neurological effects. Among rats orally exposed to both Mn and Pb, motor activity and neurotransmitter levels were significantly increased, compared with rats exposed to only 1 metal (41). Exposure to Pb and Mn decreased learning of conditioned avoidance responses more than either Pb or Mn alone, and gestational exposure to both Pb and Mn reduced brain weight to a greater extent than either metal alone (42). Each of these studies also showed that coexposure to Mn and Pb led to increased brain Pb levels, perhaps because of changes in affinity of Pb-binding proteins in the brain (43). In addition, multiplicatively greater changes in monoaminergic neurotransmitter levels occur in the brains of rats exposed to Pb and As jointly, compared either metal alone (44) or to combinations of Pb, Mn, and As. Rodriguez et al. observed that Mn and As had greater accumulation in rat brains relative to controls with single metal exposures (45). The 3 metal concentrations when combined were associated decreases in dopaminergic metabolites and increases in serotinergic metabolites. Overall, these findings are complex, but the data support the concept that coexposure to multiple metals may cause neurotoxic effects not seen with exposure to a single metal at the same dose.
Fetal programming
There is growing evidence that exposure to toxicants in early life may cause later life health effects. The observed phenomenon of "fetal origins of disease" suggests that early environmental exposures, such as metals, program later life gene expression. There is an increasing search for the biological process by which programming occurs. Because DNA sequence is static, genetic susceptibility from DNA sequence variation cannot explain the mechanisms by which prenatal or early childhood metal exposures impact cognition and behavior later in life. One possible mechanistic pathway for this phenomenon, which has yet to be fully explored in humans, is epigenetics. Epigenetics is the study of heritable changes in gene expression that occur without changes in DNA sequence. Such changes can have influences as profound as those exerted by mutations but, unlike mutations, are reversible and responsive to environmental influences. DNA methylation is the best studied of the epigenetic processes that regulate gene silencing. In general, increased methylation is inversely associated with gene expression. DNA methylation has been associated with chromosome packaging and heterochromatin formation and determines the 3-dimensional space through which transcription factors can or cannot attach to the DNA sequence. Specifically, the methylated cytosine in DNA promoter regions serves as a "mutation" of a promoter region recognition element, functionally reducing the binding affinity of the response element for its transcription factor. Although in the strictest sense epigenetics refers to changes in germ cell DNA methylation, the process of DNA methylation is critical more globally to cell differentiation and overall child development. Failure of DNA methylation systems in the brain leads to clinical syndromes such as mental retardation and autistic-like behaviors (46). Animal studies increasingly demonstrate that environmental factors can alter DNA methylation patterns and that these changes correlate with animal behavior (47).
The growing interest in epigenetic markers is a result of their potential to explain fetal origins of disease or even simply explain the latency between exposure to toxic substances and subsequent disease phenotypes. Although DNA methylation patterns in different tissues are largely constitutive, DNA methylation patterns are still subject to active regulation in the nervous system in response to environmental stimuli. Endres et al. (48) recently demonstrated that levels of DNA methylation activity in the brain are increased with ischemic injury. Others have shown that diet can impact methylation and behavior. For example, L-methionine treatment can exacerbate psychosis, whereas valproate, a drug producing hypomethylated DNA, reduces such symptoms (49,50). Epigenetic modifications of regulatory DNA sequences in response to subtle variations in environmental conditions might be a critical source of variation in gene expression and function. If so, DNA methylation changes may serve as a process mediating the relationship between genome and environment throughout neurodevelopment. The effects of prenatal/early metal exposure on DNA methylation may program environmental exposures on the fixed genome, resulting in subtle but stable alterations in later life neurophenotypes.
Metals and DNA methylation
Several studies have established an association between DNA methylation and environmental metals, including Ni, Cd, Pb, and particularly As (51–53). Oxidative stress may be a unifying process to explain these findings across different metals. Metals are known to increase reactive oxygen species production in a catalytic fashion via redox cycling (54,55). Oxidative DNA damage can interfere with the ability of methyltransferases to interact with DNA (56), thus resulting in a generalized hypomethylation of cytosine residues at CpG sites (57). In addition, Takiguchi et al. (58) showed that Cd inhibited DNA methyltransferases in a manner that was noncompetitive with respect to the DNA substrate. This finding is suggestive of interference in enzyme-DNA interaction, possibly through an interaction of Cd with the methyltransferase DNA binding domain (58).
As is the best-studied metal with effects on DNA methylation. Several in vitro studies have shown that As is associated with global DNA hypomethylation (59–61) as well as gene-specific DNA hypermethylation (62,63). This effect might be explained by the overlap between As metabolism and DNA methylation processes. Both consume S-adenosylmethionine, the universal methyl donor, which is a critical cofactor for both DNA methylation and the methylation of xenobiotics. In animal models, global DNA hypomethylation induced during gestation has been shown to perturb the function and survival of central nervous system neurons (64). Metal-induced alterations in methylation metabolism could initiate a cascade of events including gene-specific DNA hypo- or hypermethylation, resulting in aberrant gene expression and also in diminished glutathione activity leaving cells more vulnerable to oxidative stress. Although the results of these epigenetic changes on neurodevelopment have remained unexplored, given the clear importance of DNA methylation to processes of neurodevelopment, the metal-induced disruption of DNA methylation clearly deserves further study.
Neurotoxicity is a common health endpoint for excess metal exposure. Even nutritional metals, such as Fe and Mn, are neurotoxic in excess. Because real-life scenarios include exposures to multiple metals simultaneously, there is a growing need for research on mixtures of metals and their health impact. Finally, there is intriguing evidence that epigenetic phenomena may underlie observed effects of fetal or early life exposure and late onset of disease. Metals appear to alter DNA methylation, an epigenetic process by which gene expression is regulated. Further research in metals should include the role of epigenetics in determining long-term and late-onset health effects from metal exposure.
| FOOTNOTES |
|---|
2 Author disclosures: R. O. Wright and A. Baccarelli, no conflicts of interest. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Yip R. Significance of an abnormally low or high hemoglobin concentration during pregnancy: special consideration of iron nutrition. Am J Clin Nutr. 2000;72:272S–9S.
2. Goldenberg RL, Tamura T, DuBard M, Johnston KE, Copper RL, Neggers Y. Plasma ferritin and pregnancy outcome. Am J Obstet Gynecol. 1996;175:1356–9.[Medline]
3. Tamura T, Goldenberg RL, Hou J, Johnston KE, Cliver SP, Ramey SL, Nelson KG. Cord serum ferritin concentrations and mental and psychomotor development of children at five years of age. J Pediatr. 2002;140:165–70.[Medline]
4. Pinero D, Jones B, Beard J. Variations in dietary iron alter behavior in developing rats. J Nutr. 2001;131:311–8.
5. Fredriksson A, Schroder N, Eriksson P, Izquierdo I, Archer T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol. 1999;159:25–30.[Medline]
6. McMillan DE. A brief history of the neurobehavioral toxicity of manganese: some unanswered questions. Neurotoxicology. 1999;20:499–507.[Medline]
7. FDA. Food labeling reference daily intakes. Part II: Final rule. Fed Regist. 1995;60:67163–75.
8. Santos-Burgoa C, Rios C, Mercado LA, Arechiga-Serrano R, Cano-Valle F, Eden-Wynter RA, Texcalac-Sangrador JL, Villa-Barragan JP, Rodriguez-Agudelo Y, Montes S. Exposure to manganese: health effects on the general population, a pilot study in central Mexico. Environ Res. 2001;85:90–104.[Medline]
9. Verity MA. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology. 1999;20:489–97.[Medline]
10. Zheng W, Ren S, Graziano JH. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res. 1998;799:334–42.[Medline]
11. Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol. 2003;38:232–42.[Medline]
12. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med. 1955;12:21–35.[Medline]
13. Sassine MP, Mergler D, Bowler R, Hudnell HK. Manganese accentuates adverse mental health effects associated with alcohol use disorders. Biol Psychiatry. 2002;51:909–21.[Medline]
14. Wennberg A, Iregren A, Struwe G, Cizinsky G, Hagman M, Johansson L. Manganese exposure in steel smelters a health hazard to the nervous system. Scand J Work Environ Health. 1991;17:255–62.[Medline]
15. He P, Liu DH, Zhang GQ. [Effects of high-level-manganese sewage irrigation on children's neurobehavior.] Zhonghua Yu Fang Yi Xue Za Zhi. 1994;28:216–8.[Medline]
16. Crinella F, Cordova E, Ericson J. Manganese, aggression, and attention-deficit hyperactivity disorder. Neurotoxicol Teratol. 1998;19:468–9.
17. Wright RO, Amarasiriwardena C, Woolf A, Jim R, Bellinger DC. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology. 2006;27:210–6.[Medline]
18. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z, et al. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 2004;112:1329–33.[Medline]
19. Jin Y, Xi S, Li X, Lu C, Li G, Xu Y, Qu C, Niu Y, Sun G. Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environ Res. 2006;101:349–55.[Medline]
20. Rodriguez VM, Carrizales L, Mendoza MS, Fajardo OR, Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol Teratol. 2002;24:743–50.[Medline]
21. Rao MV, Avani G. Arsenic induced free radical toxicity in brain of mice. Indian J Exp Biol. 2004;42:495–8.[Medline]
22. Chaudhuri AN, Basu S, Chattopadhyay S, Das Gupta S. Effect of high arsenic content in drinking water on rat brain. Indian J Biochem Biophys. 1999;36:51–4.[Medline]
23. Chattopadhyay S, Bhaumik S, Nag Chaudhury A, Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett. 2002;128:73–84.[Medline]
24. Dakeishi M, Murata K, Grandjean P. Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder. Environ Health. 2006;5:31.[Medline]
25. Calderon J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I, Borja-Aburto V, Díaz-Barriga F. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ Res. 2001;85:69–76.[Medline]
26. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology. 2003;24:747–53.[Medline]
27. Marlowe M, Errera J, Jacobs J. Increased lead and cadmium burdens among mentally retarded children and children with borderline intelligence. Am J Ment Defic. 1983;87:477–83.[Medline]
28. Bellinger DL, Anderson WJ. Postnatal development of cell columns and their associated dendritic bundles in the lumbosacral spinal cord of the rat. I. The ventrolateral cell column. Brain Res. 1987;432:55–67.[Medline]
29. Jiang HM, Guo H, Zhu H. Clinical significance of hair cadmium content in the diagnosis of mental retardation of children. Chin Med J (Engl). 1990;103:331–4.[Medline]
30. Pihl RO, Parkes M. Hair element content in learning disabled children. Science. 1977;198:204–6.
31. Capel ID, Pinnock MH, Dorrell HM, Williams DC, Grant ECG. Comparison of concentrations of some trace, bulk, and toxic metals in the hair of normal and dyslexic children. Clin Chem. 1981;27:879–91.
32. Thatcher RW, Lester ML, McAlaster R, Horst R. Effects of low levels of cadmium and lead on cognitive functioning in children. Arch Environ Health. 1982;37:159–66.[Medline]
33. Thatcher RW, McAlaster R, Lester ML. Evoked potentials related to hair cadmium and lead in children. Ann N Y Acad Sci. 1984;425:384–90.[Medline]
34. Marlowe M, Cossairt A, Moon C, Errera J, MacNeel A, Peak R, Ray J, Schroeder C. Main and interaction effects of metallic toxins on classroom behavior. J Abnorm Child Psychol. 1985;13:185–98.[Medline]
35. Prohaska JR. Long-term functional consequences of malnutrition during brain development: copper. Nutrition. 2000;16:502–4.[Medline]
36. Rossi L, Arciello M, Capo C, Rotilio G. Copper imbalance and oxidative stress in neurodegeneration. Ital J Biochem. 2006;55:212–21.[Medline]
37. Cai L, Li XK, Song Y, Cherian MG. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem. 2005;12:2753–63.[Medline]
38. Cuajungco MP, Faget KY. Zinc takes the center stage: its paradoxical role in Alzheimer's disease. Brain Res Brain Res Rev. 2003;41:44–56.[Medline]
39. Delves HT, Clayton BE, Bicknell J. Concentration of trace metals in the blood of children. Br J Prev Soc Med. 1973;27:100–7.[Medline]
40. Zielhuis RL, del Castilho P, Herber RF, Wibowo AA. Levels of lead and other metals in human blood: suggestive relationships, determining factors. Environ Health Perspect. 1978;25:103–9.[Medline]
41. Chandra AV, Ali MM, Saxena DK, Murthy RC. Behavioral and neurochemical changes in rats simultaneously exposed to manganese and lead. Arch Toxicol. 1981;49:49–56.[Medline]
42. Chandra SV, Murthy RC, Saxena DK, Lal B. Effects of pre- and postnatal combined exposure to Pb and Mn on brain development in rats. Ind Health. 1983;21:273–9.[Medline]
43. Kalia K, Murthy RC, Chandra SV. Tissue disposition of 54Mn in lead pretreated rats. Ind Health. 1984;22:49–52.[Medline]
44. Mejia JJ, Diaz-Barriga F, Calderon J, Rios C, Jimenez-Capdeville ME. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol Teratol. 1997;19:489–97.[Medline]
45. Rodriguez VM, Dufour L, Carrizales L, Diaz-Barriga F, Jimenez-Capdeville ME. Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environ Health Perspect. 1998;106:487–91.[Medline]
46. Shahbazian MD, Zoghbi HY. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet. 2002;71:1259–72.[Medline]
47. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, Weaver V, Todd A. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology. 2005;16:106–13.[Medline]
48. Endres M, Ahmadi M, Kruman I, Biniszkiewicz D, Meisel A, Gertz K. Folate deficiency increases post-ischemic brain injury. Stroke. 2005;36:321–5.
49. Tremolizzo L, Doueiri MS, Dong E, Grayson DR, Davis J, Pinna G, Tueting P, Rodriguez-Menendez V, Costa E, Guidotti A.Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry. 2005;57:500–9.[Medline]
50. Alonso-Aperte E, Ubeda N, Achon M, Perez-Miguelsanz J, Varela-Moreiras G. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology. 1999;52:750–6.
51. McVeigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond). 2001;100:387–93.[Medline]
52. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: Linking early developmental environment to adult disease. Reprod Toxicol. 2007;23:297–307.[Medline]
53. Bleich S, Lenz B, Ziegenbein M, Beutler S, Frieling H, Kornhuber J, Bönsch D. Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res. 2006;30:587–91.[Medline]
54. Fowler BA, Whittaker MH, Lipsky M, Wang G, Chen XQ. Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats: an overview. Biometals. 2004;17:567–8.[Medline]
55. Shen XM, Dryhurst G. Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity. Chem Res Toxicol. 1998;11:824–37.[Medline]
56. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004;32:4100–8.
57. Turk PW, Laayoun A, Smith SS, Weitzman SA. DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis. 1995;16:1253–5.
58. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res. 2003;286:355–65.[Medline]
59. Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun. 2007;352:188–92.[Medline]
60. Sciandrello G, Caradonna F, Mauro M, Barbata G. Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis. 2004;25:413–7.
61. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis. 2004;25:1779–86.
62. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D. DNA hypermethylation of promoter of gene p53 and p16 in arsenic exposed people with and without malignancy. Toxicol Sci. 2006;89:431–7.
63. Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol. 2001;175:260–8.[Medline]
64. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, Henning SM, Swendseid ME. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr. 1998;128:1204–12.
This article has been cited by other articles:
![]() |
A. Baccarelli, R. O. Wright, V. Bollati, L. Tarantini, A. A. Litonjua, H. H. Suh, A. Zanobetti, D. Sparrow, P. S. Vokonas, and J. Schwartz Rapid DNA Methylation Changes after Exposure to Traffic Particles Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 572 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kordas, B. Lonnerdal, and R. J. Stoltzfus Interactions between Nutrition and Environmental Exposures: Effects on Health Outcomes in Women and Children J. Nutr., December 1, 2007; 137(12): 2794 - 2797. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||